Imaging - November 24, 2025
Moleculent launches early access program
The company's new program gives selected researchers the opportunity to test the company’s new platform, which reveals how cells communicate within tissue.
Global report - November 24, 2025
AstraZeneca plans USD 2 billion manufacturing investment in Maryland
This is the fourth major US manufacturing investment announced this year.
Agreement - November 24, 2025
Sprint Bioscience sells the TREX1 program to Gilead
The agreement includes an upfront payment of USD 14 million, as well as potential clinical, regulatory, and commercial milestone payments totaling up to USD 400 million.
Collaboration - November 21, 2025
Mercodia and Attana collaborate
The two companies are entering into a strategic collaboration with the goal of developing next-generation solutions in preclinical drug development.
Clinical Trials - November 21, 2025
Evaxion announces positive data for lead antigens in CMV vaccine program
Evaxion is advancing its novel multi-component cytomegalovirus (CMV) vaccine program, EVX-V1, with new data demonstrating protective effects of lead antigens in the program.
Biotech Business - November 21, 2025
Alvotech and Advanz Pharma receive marketing approval across the European Economic Area
The European Commission (EC) has granted marketing authorizations in the European Economic Area (EEA) for Gobivaz, Alvotech’s biosimilar to Simponi (golimumab).
